Onderstepoort Biological Products have indicated that progress has been made with equipment upgrades, troubleshooting production processes and staff training, which has affected the production and availability of vaccines. OBP supplied the table below which summarises key products that have been produced and what should be expected late November and early December 2014.
| Products | Doses released | Doses expected late November 2014 |
| Bluetongue | 1 000 000 (available) | 2 000 000 |
| AHS | 29 820 (last week) | 360 000 |
| Brucella S19 | 320 000 | 135 000 |
| B. phemeral | In test | 37 560 |
| Rift Valley fever live | 2 083 300 (available) | Same quantities still available |
| Rift Valley fever inactive | In test | >25 000 |
For more information or clarification, please contact Dr Jacob Modumo at 012 522 1518 or 082 547 1115.
Published on Monday, 24th November 2014 - 09:05
Recent Posts
disclaimer